Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
MicroRNA-155 is induced during the macrophage inflammatory response
2007 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
2013
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
1995
Untangling the ErbB signalling network
2001 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections
1996
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2018
2018 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody
1990
Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review
2015
A view on drug resistance in cancer
2019 StandoutNature
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
2001
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization
1999
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Cytogenetics of non‐small cell lung cancer: Analysis of consistent non‐random abnormalities
1990
Cushing's syndrome
2015 Standout
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
2016
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 Standout
Immunology and immunotherapy approaches for prostate cancer
2007
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Psychosocial Effects of Cancer Cachexia: A Systematic Literature Search and Qualitative Analysis
2012
Molecular Analysis of the Short Arm of Chromosome 3 in Small-Cell and Non-Small-Cell Carcinoma of the Lung
1987
Transforming growth factor-β in cancer and metastasis
2006
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.
1991
Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma
2000
Understanding the mechanisms and treatment options in cancer cachexia
2012
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Cancer-associated cachexia
2018 Standout
Minimal Methylated Substrate and Extended Substrate Range of Escherichia coli AlkB Protein, a 1-Methyladenine-DNA Dioxygenase
2003 StandoutNobel
Simultaneous detection of epidermal growth factor receptor (EGF‐R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method
1988
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Growth control by epidermal growth factor and transforming growth factor-α in human lung squamous carcinoma cells
1992
A Translational View of the Molecular Pathogenesis of Lung Cancer
2007
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
2015
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
2017
Taking dendritic cells into medicine
2007 StandoutNatureNobel
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Epidermal growth factor receptors in lung tumours
1987
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Emerging Biological Principles of Metastasis
2017 Standout
Sarcopenia
2019 Standout
Immunotherapy for prostate cancer
2006
Targeting metastasis
2016
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Gastric cancer
2020 Standout
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
2014
Stem Cells and Cancer
2004 Standout
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
2010
Pancreatic Cancer
2010 Standout
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
2009
Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
2011
Food connections: A qualitative exploratory study of weight- and eating-related distress in families affected by advanced cancer
2015
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer
2005
Immunotherapy for prostate cancer
2007
Advances in Malignant Mesothelioma
2005 Standout
A systematic review of health-related quality of life instruments in patients with cancer cachexia
2013
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
2004
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
2001
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Epidermal growth factor receptors in non-small cell lung cancer
1987
Bladder Cancer
2020 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
2005
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers
2015
Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
2001
Cancer statistics, 2016
2016 Standout
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
1989 StandoutScience
Prognostic Factors in Patients With Advanced Cancer: Use of the Patient-Generated Subjective Global Assessment in Survival Prediction
2010
The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
2013
Defective processing of methylated single-stranded DNA by E. coli alkB mutants
2000 StandoutNobel
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia
2015
Cannabinoids for Medical Use
2015 Standout
Psychosocial impact of cancer cachexia
2014
A mixed-methods qualitative research study to develop a complex intervention for weight loss and anorexia in advanced cancer: The Family Approach to Weight and Eating
2014
Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival
1989
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.
1996
Works of Thomas Cerny being referenced
Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients
2014
Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis
2017
Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma
1992
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
2006
Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis
2014
Modest Improvement in Overall Survival for Patients With Metastatic Pancreatic Cancer
2013
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
1996
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
2007
Expression of epidermal growth factor receptor (EGF-R) in human lung tumours
1986
Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
2006
Genetic predisposition to human lung cancer
1986
Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
2013
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
2011
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
2000